KHAN Technology Transfer Fund Overview

KHAN Technology Transfer Fund is an early-stage life sciences venture fund managed by Khanu Fondsverwaltung GmbH. The fund aims to create value through cooperative drug development partnerships with academic innovators in Europe, focusing on first-in-class therapies for markets with high unmet medical needs. KHAN has unique access to cutting-edge scientific research at Max Planck Institutes and other leading European academic institutions. The fund is supported by the European Investment Fund (EIF), Akros Pharma Inc., the Max Planck Foundation, and Thyssen’sche Handelsgesellschaft, among others. Investments are executed at the Lead Discovery Center GmbH (LDC) in Dortmund, a professional drug discovery and translational research incubator.

Is KHAN Technology Transfer Fund the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with KHAN Technology Transfer Fund, along with a list of other relevant VCs, is available on Hopohopo.io.